Skip to main navigation Skip to search Skip to main content

Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

Research output: Contribution to conferencePresentation

Original languageAmerican English
DOIs
StatePublished - May 20 2019
EventJournal of Clinical Oncology -
Duration: Jan 1 2020 → …

Conference

ConferenceJournal of Clinical Oncology
Period1/1/20 → …

Disciplines

  • Oncology
  • Pathology
  • Medicine and Health Sciences

Cite this